China's New Anti-Monopoly Law: Let The Games Begin
Tuesday, September 9, 2008
8:00 a.m. to 9:00 a.m. (PDT)
11:00 a.m. to 12:00 p.m. (EDT)
4:00 p.m. to 5:00 p.m. (BST)
The Olympics weren't the only major launch in China in August; China's first comprehensive competition law commenced on August 1, 2008. The new Anti-Monopoly Law (AML) provides a legislative framework upon which China looks to build an enforcement regime as significant and far-reaching as those of Europe and the United States. The AML regulates or prohibits many trade practices that were previously common in China, and it is vital that businesses with operations, customers or investments in China understand how the new law may affect them.
Please join Gerry O'Brien, Hannah Ha and John Hickin, solicitors in Mayer Brown's Hong Kong office with extensive experience in antitrust and competition issues in China, as they discuss the AML and its implications for both foreign and domestic-China businesses.
The discussion will focus on:
- The unique features and processes of China's competition regime and how these will impact administration and enforcement of the AML.
- Key potential risk areas and recommendations on how businesses can optimize their compliance endeavors.
- Current information on the AML pre-merger notification regime, including relevant implementation rules specifying the threshold tests for notification, and guidance on the many "grey areas" relating to the regime.
- The expected areas of primary focus and investigation by Chinese enforcement agencies.
- Particular issues the law may raise in the areas of intellectual property, foreign investment in China, pricing, assessment and impact of market dominance, and the prospects for fair treatment of foreign business under the law.
The team will also provide a brief update on competition law developments in Hong Kong, where the government is moving to introduce a controversial new Competition Ordinance.
CLE credit is pending.
Instructions for accessing the program will be sent prior to the event.
For additional information please contact Erin Johnson at +1 202 263 3086 or email@example.com.